Expertise in
18
conditions
Expertise in
18
conditions
UF Health Pediatric Blood & Marrow Transplant And Cellular Therapy
1600 SW Archer Rd Fl 4, 
Gainesville, FL 

Overview

William Slayton is a Pediatrics provider in Gainesville, Florida. Dr. Slayton is highly rated in 18 conditions, according to our data. His top areas of expertise are Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Aspiration.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 86 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Florida College Of Medicine

Specialties

Pediatrics

Licenses

Pediatric Hematology-Oncology in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

UF Health Pediatric Blood & Marrow Transplant and Cellular Therapy
1600 SW Archer Rd Fl 4, Gainesville, FL 32610
Other Locations
UF Health Pediatric Infusion Center & Specialties Clinic
1600 SW Archer Rd Fl Fourth, Gainesville, FL 32610

Additional Areas of Focus

Dr. Slayton has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


86 Clinical Trials

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
View 39 Less Clinical Trials
Similar Doctors
Expertise in
9
conditions
Pediatrics
Expertise in
9
conditions
Pediatrics

UF Health Center For Pediatric Neuromuscular And Rare Diseases

1549 Gale Lemerand Dr Fl Second, 
Gainesville, FL 
 (1.7 miles away)
Languages Spoken:
English

Barry Byrne is a Pediatrics provider in Gainesville, Florida. Dr. Byrne is highly rated in 9 conditions, according to our data. His top areas of expertise are Pompe Disease, Barth Syndrome, Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, and Bone Marrow Aspiration.

Expertise in
2
conditions
Pediatrics
Expertise in
2
conditions
Pediatrics

Uf Health Medical Lab-Shands Hospital

1600 SW Archer Rd, 
Gainesville, FL 
 (0.4 miles away)
Languages Spoken:
English

Eric Nelson is a Pediatrics provider in Gainesville, Florida. Dr. Nelson is highly rated in 2 conditions, according to our data. His top areas of expertise are Diarrhea and Undescended Testicle.

Expertise in
5
conditions
Expertise in
5
conditions

Uf Health Pediatric Specialties-Medical Plaza

1549 Gale Lemerand Dr Fl Second, 
Gainesville, FL 
 (1.7 miles away)
Languages Spoken:
English

Desmond Schatz is a Pediatrics provider in Gainesville, Florida. Dr. Schatz is highly rated in 5 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Type 2 Diabetes (T2D), and Low Blood Sugar.

Frequently Asked Questions about Dr. William Slayton

How do I make an appointment with Dr. William Slayton?

You can book an appointment with Dr. William Slayton by calling their office at 352-273-9120. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. William Slayton a top-rated expert for Langerhans Cell Histiocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. William Slayton is classified as an Advanced expert for Langerhans Cell Histiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. William Slayton specialize in?

While Dr. William Slayton is a Pediatrics, they have specific expertise in Langerhans Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. William Slayton participate in research or clinical trials?

Yes. Dr. William Slayton has published 43 articles and abstracts on conditions like Langerhans Cell Histiocytosis. You can view a list of Dr. William Slayton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. William Slayton accept my insurance?

Dr. William Slayton accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 352-273-9120 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Slayton's expertise for a condition
ConditionClose
      View All 18 Advanced Conditions
      View All 15 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile